Attached files
file | filename |
---|---|
8-K - MusclePharm Corp | form8-k.htm |
Exhibit 16
June 10, 2021
Securities and Exchange Commission
Washington, D.C. 20549
Commissioners:
We have read MusclePharm Corporation’s statements included under Item 4.01(a) of its Form 8-K filed on June 10, 2021 and we agree with such statements concerning our firm.